The Blood Matters program is underpinned by the Department’s values, vision, and priorities. Read more about the priorities on the Our priorities page.
The program aims to support best practice in all areas related to blood management safety and governance.
The content of these pages is intended for use by health care staff; clinical, quality, and scientific.
What's new
-
While STIR does not accept reports of intravenous immunoglobulin (IVIg) reactions, recent changes to immunoglobulin products highlight the importance of recognising and reporting IVIg reactions. This STIR bulletin focuses on IVIg reactions, recognition and reporting.
STIR bulletin No. 12 - Intravenous immunoglobulin reactionsSTIR bulletin No. 12 - Intravenous immunoglobulin reactionsSee more at Serious Transfusion Incident Reporting (STIR).
- Blood Matters on the Bench and Beyond May 2025Blood Matters on the Bench and Beyond May 2025
Previous versions are available on Transfusion science and blood stewardship page.
-
The 2025 audit focuses on the pretransfusion patient identification and product check. Details of the audit are now available on Blood Matters audits.
-
The report is an overview of the Blood Matters program activities and plans intended for distribution to blood management committees (or equivalent).
February 2025 - Blood Management Committee reportFebruary 2025 - Blood Management Committee reportSee previous reports on Resources and education.
-
Following the release of Beriplex, a four-factor prothrombin complex concentrate, there has been an update to the recommendations for warfarin reversal.
For more information, see Clinical education resources on Resources and education – blood transfusion.
Reviewed 27 June 2025